Monthly
US$200
Billed every month
Piracetam Injection(吡拉西坦注射液)
Companies, stages and changes, with each record available on this page.
No changes recorded by this site in the last 90 days
Complete CDE snapshot: 2026/11/10 07:27
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders34View records ↓
Under-review filings9View records ↓
This year’s generic filers4View records ↓
NHSA approval numbers81View records ↓
API companies with A status16View records ↓
Chemical-drug catalogue
Loaded records: 34 holders; 13 in the quality-and-efficacy consistency-evaluation category, and 21 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 亚邦医药股份有限公司 | 亚邦医药股份有限公司 | 国药准字H20265995 | 2026/09/15 | 5ml：1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京四环科宝制药股份有限公司 | 北京四环科宝制药股份有限公司 | 国药准字H20265604 | 2026/08/04 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石药银湖制药有限公司 | 石药银湖制药有限公司 | 国药准字H20265250 | 2026/07/21 | 5ml：1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 嘉亨(珠海横琴)医药科技有限公司 | 裕松源药业有限公司 | 国药准字H20264680 | 2026/06/10 | 15ml︰3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 嘉亨(珠海横琴)医药科技有限公司 | 河南福森药业有限公司 | 国药准字H20264679 | 2026/06/10 | 5ml︰1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东力诺制药有限公司 | 山东方明药业集团股份有限公司 | 国药准字H20264088 | 2026/04/21 | 10ml：2g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东力诺制药有限公司 | 山东方明药业集团股份有限公司 | 国药准字H20264087 | 2026/04/21 | 5ml：1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西藏兴崃药业有限公司 | 成都天台山制药股份有限公司 | 国药准字H20263301 | 2026/02/02 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西藏兴崃药业有限公司 | 成都天台山制药股份有限公司 | 国药准字H20263302 | 2026/02/02 | 15ml:3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南利欣制药股份有限公司 | 河南利欣制药股份有限公司 | 国药准字H20057744 | 2026/01/28 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 北京四环科宝制药股份有限公司 | 北京四环科宝制药股份有限公司 | 国药准字H20263020 | 2026/01/05 | 15ml:3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海锦帝九州药业（安阳）有限公司 | 上海锦帝九州药业（安阳）有限公司 | 国药准字H41024686 | 2025/12/05 | 20ml:4g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 上海锦帝九州药业（安阳）有限公司 | 上海锦帝九州药业（安阳）有限公司 | 国药准字H41024685 | 2025/12/05 | 5ml：1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东新华制药股份有限公司 | 山东新华制药股份有限公司 | 国药准字H37023216 | 2025/11/24 | 10ml：2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 西安达莫制药有限公司 | 山东华鲁制药有限公司 | 国药准字H20255096 | 2025/08/19 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西安达莫制药有限公司 | 山东华鲁制药有限公司 | 国药准字H20255095 | 2025/08/19 | 15ml:3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南赛隆药业（长沙）有限公司 | 湖南赛隆药业（长沙）有限公司 | 国药准字H20254789 | 2025/07/08 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南赛隆药业（长沙）有限公司 | 湖南赛隆药业（长沙）有限公司 | 国药准字H20254788 | 2025/07/08 | 15ml:3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川新斯顿制药股份有限公司 | 四川新斯顿制药股份有限公司 | 国药准字H20254518 | 2025/06/10 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东化药医药科技有限公司 | 西安远大德天药业股份有限公司 | 国药准字H20254229 | 2025/05/20 | 5ml：1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东化药医药科技有限公司 | 西安远大德天药业股份有限公司 | 国药准字H20254228 | 2025/05/20 | 10ml：2g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东化药医药科技有限公司 | 西安远大德天药业股份有限公司 | 国药准字H20254227 | 2025/05/20 | 15ml：3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄凯达生物工程有限公司 | 石家庄凯达生物工程有限公司 | 国药准字H20253690 | 2025/03/25 | 20ml:4g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄凯达生物工程有限公司 | 石家庄凯达生物工程有限公司 | 国药准字H20253689 | 2025/03/25 | 15ml:3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄凯达生物工程有限公司 | 石家庄凯达生物工程有限公司 | 国药准字H20253688 | 2025/03/25 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 合肥国药诺和药业有限公司 | 国药集团国瑞药业有限公司 | 国药准字H20253599 | 2025/03/11 | 15ml:3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 合肥国药诺和药业有限公司 | 国药集团国瑞药业有限公司 | 国药准字H20253600 | 2025/03/11 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 辅仁药业集团有限公司 | 辅仁药业集团有限公司 | 国药准字H20068162 | 2025/01/26 | 5ml：1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 福建省闽东力捷迅药业股份有限公司 | 山东罗欣药业集团股份有限公司 | 国药准字H20249776 | 2024/12/25 | 5ml : 1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 福建省闽东力捷迅药业股份有限公司 | 山东罗欣药业集团股份有限公司 | 国药准字H20249777 | 2024/12/25 | 15ml : 3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏联环药业股份有限公司 | 江苏联环药业股份有限公司 | 国药准字H20044950 | 2024/10/28 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江苏苏中药业集团生物制药有限公司 | 江苏苏中药业集团生物制药有限公司 | 国药准字H20055345 | 2024/07/09 | 20ml:4g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 华润双鹤利民药业（济南）有限公司 | 华润双鹤利民药业（济南）有限公司 | 国药准字H20046577 | 2024/05/07 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 吉林省辉南长龙生化药业股份有限公司 | 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20243247 | 2024/02/23 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华夏生生药业（北京）有限公司 | 华夏生生药业（北京）有限公司 | 国药准字H20243198 | 2024/02/20 | 5ml∶1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华夏生生药业（北京）有限公司 | 华夏生生药业（北京）有限公司 | 国药准字H20243199 | 2024/02/20 | 15ml∶3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西亿友药业有限公司 | 马鞍山丰原制药有限公司 | 国药准字H20243100 | 2024/01/30 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南科伦药业有限公司 | 河南科伦药业有限公司 | 国药准字H20243105 | 2024/01/30 | 5ml:1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西亿友药业有限公司 | 马鞍山丰原制药有限公司 | 国药准字H20243101 | 2024/01/30 | 15ml:3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 黑龙江福和制药集团股份有限公司 | 黑龙江福和制药集团股份有限公司 | 国药准字H11021884 | 2024/01/22 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖北津药药业股份有限公司 | 湖北津药药业股份有限公司 | 国药准字H20093517 | 2023/10/27 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 东北制药集团沈阳第一制药有限公司 | 东北制药集团沈阳第一制药有限公司 | 国药准字H21022754 | 2023/10/27 | 5ml∶1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东方明药业集团股份有限公司 | 山东方明药业集团股份有限公司 | 国药准字H20237125 | 2023/10/12 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 珠海和凡医药股份有限公司 | 山东威高药业股份有限公司 | 国药准字H20234200 | 2023/09/28 | 5ml：1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 珠海和凡医药股份有限公司 | 山东威高药业股份有限公司 | 国药准字H20234201 | 2023/09/28 | 15ml：3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南全星制药有限公司 | 海南全星制药有限公司 | 国药准字H20234054 | 2023/08/22 | 15ml：3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南全星制药有限公司 | 海南全星制药有限公司 | 国药准字H20234053 | 2023/08/22 | 5ml：1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海现代哈森(商丘)药业有限公司 | 上海现代哈森(商丘)药业有限公司 | 国药准字H20067957 | 2023/06/29 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 上海现代哈森(商丘)药业有限公司 | 上海现代哈森(商丘)药业有限公司 | 国药准字H20237071 | 2023/06/29 | 15ml:3g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东新华制药股份有限公司 | 山东新华制药股份有限公司 | 国药准字H37023217 | 2023/02/01 | 5ml：1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 广东鼎信医药科技有限公司 | 广东星昊药业有限公司 | 国药准字H20227156 | 2022/11/11 | 15ml:3g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 广东鼎信医药科技有限公司 | 广东星昊药业有限公司 | 国药准字H22024151 | 2022/11/11 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 瑞阳制药股份有限公司 | 瑞阳制药股份有限公司 | 国药准字H20223288 | 2022/05/10 | 10ml：2g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东玉满坤生物科技有限公司 | 山东齐都药业有限公司 | 国药准字H20223199 | 2022/04/08 | 5ml：1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东玉满坤生物科技有限公司 | 山东齐都药业有限公司 | 国药准字H20223200 | 2022/04/08 | 15ml：3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏苏中药业集团生物制药有限公司 | 江苏苏中药业集团生物制药有限公司 | 国药准字H20055344 | 2024/07/09 | 5ml:1g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 81 distinct approval numbers and 47 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 黑龙江福和制药集团股份有限公司 | 国药准字H11021884 | 5ml:1g | Category B (乙) | XN07XXB093B002010100075 | NHSA |
| 北京四环科宝制药股份有限公司 | 国药准字H20265604 | 5ml:1g | Category B (乙) | XN07XXB093B002010100151 | NHSA |
| 广东鼎信医药科技有限公司 | 国药准字H20227156 | 15ml:3g | Category B (乙) | XN07XXB093B002010100198 | NHSA |
| 上海上药第一生化药业有限公司 | 国药准字H31022564 | 5ml:1g | Category B (乙) | XN07XXB093B002010100651 | NHSA |
| 上海旭东海普药业有限公司 | 国药准字H20059626 | 20ml:4g | Category B (乙) | XN07XXB093B002010100808 | NHSA |
| 天津红日药业股份有限公司 | 国药准字H12021096 | 5ml:1g | Category B (乙) | XN07XXB093B002010100864 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50021691 | 5ml:1g | Category B (乙) | XN07XXB093B002010101066 | NHSA |
| 丹东医创药业有限责任公司 | 国药准字H21022777 | 5ml:1g | Category B (乙) | XN07XXB093B002010101157 | NHSA |
| 东北制药集团沈阳第一制药有限公司 | 国药准字H21022754 | 5ml:1g | Category B (乙) | XN07XXB093B002010101161 | NHSA |
| 辽宁天龙药业有限公司 | 国药准字H21022834 | 5ml:1g | Category B (乙) | XN07XXB093B002010101258 | NHSA |
| 常州制药厂有限公司 | 国药准字H32025427 | 5ml:1g | Category B (乙) | XN07XXB093B002010101397 | NHSA |
| 江苏苏中药业集团生物制药有限公司 | 国药准字H20055343 | 20ml:8g | Category B (乙) | XN07XXB093B002010101493 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32026628 | 2ml:0.5g | Category B (乙) | XN07XXB093B002010101723 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20093517 | 5ml:1g | Category B (乙) | XN07XXB093B002010101866 | NHSA |
| 武汉久安药业有限公司 | 国药准字H42022301 | 20ml:4g | Category B (乙) | XN07XXB093B002010101949 | NHSA |
| 西藏兴崃药业有限公司 | 国药准字H20263301 | 5ml:1g | Category B (乙) | XN07XXB093B002010102066 | NHSA |
| 石家庄凯达生物工程有限公司 | 国药准字H20253688 | 5ml:1g | Category B (乙) | XN07XXB093B002010102679 | NHSA |
| 山西太原药业有限公司 | 国药准字H14024030 | 20ml :4g | Category B (乙) | XN07XXB093B002010102944 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H14023038 | 5ml:1g | Category B (乙) | XN07XXB093B002010102946 | NHSA |
| 上海锦帝九州药业(安阳)有限公司 | 国药准字H41024685 | 5ml:1g | Category B (乙) | XN07XXB093B002010102994 | NHSA |
| 辅仁药业集团有限公司 | 国药准字H20068162 | 5ml:1g | Category B (乙) | XN07XXB093B002010103010 | NHSA |
| 河南福森药业有限公司 | 国药准字H20057997 | 20ml:8g | Category B (乙) | XN07XXB093B002010103020 | NHSA |
| 河南科伦药业有限公司 | 国药准字H20243105 | 5ml:1g | Category B (乙) | XN07XXB093B002010103063 | NHSA |
| 河南利欣制药股份有限公司 | 国药准字H20057744 | 5ml︰1g | Category B (乙) | XN07XXB093B002010103168 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20054824 | 20ml:4g | Category B (乙) | XN07XXB093B002010103202 | NHSA |
| 广东鼎信医药科技有限公司 | 国药准字H22024151 | 5ml:1g | Category B (乙) | XN07XXB093B002010103331 | NHSA |
| 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20243247 | 5ml:1g | Category B (乙) | XN07XXB093B002010103421 | NHSA |
| 吉林省集安益盛药业股份有限公司 | 国药准字H20103232 | 5ml:1g | Category B (乙) | XN07XXB093B002010103425 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H23022875 | 5ml:1g | Category B (乙) | XN07XXB093B002010103820 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20046578 | 20ml:4g | Category B (乙) | XN07XXB093B002010103973 | NHSA |
| 山东方明药业集团股份有限公司 | 国药准字H20041294 | 20ml:4g | Category B (乙) | XN07XXB093B002010104083 | NHSA |
| 山东玉满坤生物科技有限公司 | 国药准字H20223199 | 5ml:1g | Category B (乙) | XN07XXB093B002010104145 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20223288 | 10ml:2g | Category B (乙) | XN07XXB093B002010104152 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20234200 | 5ml:1g | Category B (乙) | XN07XXB093B002010104177 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H37023216 | 10ml:2g | Category B (乙) | XN07XXB093B002010104187 | NHSA |
| 江西亿友药业有限公司 | 国药准字H20243101 | 15ml:3g | Category B (乙) | XN07XXB093B002010104287 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H33022592 | 20ml:4g | Category B (乙) | XN07XXB093B002010104494 | NHSA |
| 浙江瑞新药业股份有限公司 | 国药准字H33022533 | 20ml:4g | Category B (乙) | XN07XXB093B002010104691 | NHSA |
| 福建省闽东力捷迅药业股份有限公司 | 国药准字H20249776 | 5ml:1g | Category B (乙) | XN07XXB093B002010104799 | NHSA |
| 海南全星制药有限公司 | 国药准字H20234053 | 5ml:1g | Category B (乙) | XN07XXB093B002010105765 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20243198 | 5ml∶1g | Category B (乙) | XN07XXB093B002010109910 | NHSA |
| 亚邦医药股份有限公司 | 国药准字H20265995 | 5ml:1g | Category B (乙) | XN07XXB093B002010110144 | NHSA |
| 江西亿友药业有限公司 | 国药准字H20243100 | 5ml:1g | Category B (乙) | XN07XXB093B002010181644 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20264087 | 5ml:1g | Category B (乙) | XN07XXB093B002010183093 | NHSA |
| 西安达莫制药有限公司 | 国药准字H20255096 | 5ml:1g | Category B (乙) | XN07XXB093B002010183239 | NHSA |
| 合肥国药诺和药业有限公司 | 国药准字H20253599 | 15ml:3g | Category B (乙) | XN07XXB093B002010183719 | NHSA |
| 湖南赛隆药业(长沙)有限公司 | 国药准字H20254788 | 15ml:3g | Category B (乙) | XN07XXB093B002010183840 | NHSA |
| 嘉亨(珠海横琴)医药科技有限公司 | 国药准字H20264680 | 15ml:3g | Category B (乙) | XN07XXB093B002010184183 | NHSA |
| 黑龙江福和制药集团股份有限公司 | 国药准字H11021884 | 5ml:1g | Category B (乙) | XN07XXB093B002010200075 | NHSA |
| 广东鼎信医药科技有限公司 | 国药准字H20227156 | 15ml:3g | Category B (乙) | XN07XXB093B002010200198 | NHSA |
| 上海上药第一生化药业有限公司 | 国药准字H31022564 | 5ml:1g | Category B (乙) | XN07XXB093B002010200651 | NHSA |
| 丹东医创药业有限责任公司 | 国药准字H21022777 | 5ml:1g | Category B (乙) | XN07XXB093B002010201157 | NHSA |
| 常州制药厂有限公司 | 国药准字H32025427 | 5ml:1g | Category B (乙) | XN07XXB093B002010201397 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32026628 | 2ml:0.5g | Category B (乙) | XN07XXB093B002010201723 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20044950 | 5ml:1g | Category B (乙) | XN07XXB093B002010201743 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20093517 | 5ml:1g | Category B (乙) | XN07XXB093B002010201866 | NHSA |
| 武汉久安药业有限公司 | 国药准字H42022301 | 20ml:4g | Category B (乙) | XN07XXB093B002010201949 | NHSA |
| 西藏兴崃药业有限公司 | 国药准字H20263301 | 5ml:1g | Category B (乙) | XN07XXB093B002010202066 | NHSA |
| 石家庄凯达生物工程有限公司 | 国药准字H20253688 | 5ml:1g | Category B (乙) | XN07XXB093B002010202679 | NHSA |
| 山西太原药业有限公司 | 国药准字H14024030 | 20ml :4g | Category B (乙) | XN07XXB093B002010202944 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H14023038 | 5ml:1g | Category B (乙) | XN07XXB093B002010202946 | NHSA |
| 上海锦帝九州药业(安阳)有限公司 | 国药准字H41024685 | 5ml:1g | Category B (乙) | XN07XXB093B002010202994 | NHSA |
| 辅仁药业集团有限公司 | 国药准字H20068162 | 5ml:1g | Category B (乙) | XN07XXB093B002010203010 | NHSA |
| 河南科伦药业有限公司 | 国药准字H20243105 | 5ml:1g | Category B (乙) | XN07XXB093B002010203063 | NHSA |
| 河南利欣制药股份有限公司 | 国药准字H20057744 | 5ml︰1g | Category B (乙) | XN07XXB093B002010203168 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20054824 | 20ml:4g | Category B (乙) | XN07XXB093B002010203202 | NHSA |
| 广东鼎信医药科技有限公司 | 国药准字H22024151 | 5ml:1g | Category B (乙) | XN07XXB093B002010203331 | NHSA |
| 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20243247 | 5ml:1g | Category B (乙) | XN07XXB093B002010203421 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H23022875 | 5ml:1g | Category B (乙) | XN07XXB093B002010203820 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20046578 | 20ml:4g | Category B (乙) | XN07XXB093B002010203973 | NHSA |
| 山东方明药业集团股份有限公司 | 国药准字H20041294 | 20ml:4g | Category B (乙) | XN07XXB093B002010204083 | NHSA |
| 山东玉满坤生物科技有限公司 | 国药准字H20223199 | 5ml:1g | Category B (乙) | XN07XXB093B002010204145 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20223288 | 10ml:2g | Category B (乙) | XN07XXB093B002010204152 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20234200 | 5ml:1g | Category B (乙) | XN07XXB093B002010204177 | NHSA |
| 江西亿友药业有限公司 | 国药准字H20243101 | 15ml:3g | Category B (乙) | XN07XXB093B002010204287 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H33022592 | 20ml:4g | Category B (乙) | XN07XXB093B002010204494 | NHSA |
| 浙江瑞新药业股份有限公司 | 国药准字H33022533 | 20ml:4g | Category B (乙) | XN07XXB093B002010204691 | NHSA |
| 福建省闽东力捷迅药业股份有限公司 | 国药准字H20249776 | 5ml:1g | Category B (乙) | XN07XXB093B002010204799 | NHSA |
| 海南全星制药有限公司 | 国药准字H20234053 | 5ml:1g | Category B (乙) | XN07XXB093B002010205765 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20243198 | 5ml∶1g | Category B (乙) | XN07XXB093B002010209910 | NHSA |
| 江西亿友药业有限公司 | 国药准字H20243100 | 5ml:1g | Category B (乙) | XN07XXB093B002010281644 | NHSA |
| 西安达莫制药有限公司 | 国药准字H20255096 | 5ml:1g | Category B (乙) | XN07XXB093B002010283239 | NHSA |
| 合肥国药诺和药业有限公司 | 国药准字H20253599 | 15ml:3g | Category B (乙) | XN07XXB093B002010283719 | NHSA |
| 湖南赛隆药业(长沙)有限公司 | 国药准字H20254788 | 15ml:3g | Category B (乙) | XN07XXB093B002010283840 | NHSA |
| 常州制药厂有限公司 | 国药准字H32025427 | 5ml:1g | Category B (乙) | XN07XXB093B002010301397 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32026628 | 2ml:0.5g | Category B (乙) | XN07XXB093B002010301723 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20044950 | 5ml:1g | Category B (乙) | XN07XXB093B002010301743 | NHSA |
| 河南科伦药业有限公司 | 国药准字H20243105 | 5ml:1g | Category B (乙) | XN07XXB093B002010303063 | NHSA |
| 海南全星制药有限公司 | 国药准字H20234053 | 5ml:1g | Category B (乙) | XN07XXB093B002010305765 | NHSA |
| 黑龙江福和制药集团股份有限公司 | 国药准字H11021885 | 20ml:4g | Category B (乙) | XN07XXB093B002020100075 | NHSA |
| 上海旭东海普药业有限公司 | 国药准字H20059626 | 20ml:4g | Category B (乙) | XN07XXB093B002020100808 | NHSA |
| 天津红日药业股份有限公司 | 国药准字H12021095 | 20ml:4g | Category B (乙) | XN07XXB093B002020100864 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50021692 | 20ml:4g | Category B (乙) | XN07XXB093B002020101066 | NHSA |
| 东北制药集团沈阳第一制药有限公司 | 国药准字H21022754 | 5ml:1g | Category B (乙) | XN07XXB093B002020101161 | NHSA |
| 辽宁天龙药业有限公司 | 国药准字H21022833 | 20ml:4g | Category B (乙) | XN07XXB093B002020101258 | NHSA |
| 江苏苏中药业集团生物制药有限公司 | 国药准字H20055344 | 5ml:1g | Category B (乙) | XN07XXB093B002020101493 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32025602 | 5ml:1g | Category B (乙) | XN07XXB093B002020101723 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20093518 | 20ml:4g | Category B (乙) | XN07XXB093B002020101866 | NHSA |
| 西藏兴崃药业有限公司 | 国药准字H20263302 | 15ml:3g | Category B (乙) | XN07XXB093B002020102066 | NHSA |
| 石家庄凯达生物工程有限公司 | 国药准字H20253689 | 15ml:3g | Category B (乙) | XN07XXB093B002020102679 | NHSA |
| 上海锦帝九州药业(安阳)有限公司 | 国药准字H41024686 | 20ml:4g | Category B (乙) | XN07XXB093B002020102994 | NHSA |
| 河南福森药业有限公司 | 国药准字H20057997 | 20ml:8g | Category B (乙) | XN07XXB093B002020103020 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20067957 | 5ml:1g | Category B (乙) | XN07XXB093B002020103202 | NHSA |
| 广东鼎信医药科技有限公司 | 国药准字H22024146 | 20ml:4g | Category B (乙) | XN07XXB093B002020103331 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H23022874 | 20ml:4g | Category B (乙) | XN07XXB093B002020103820 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20046577 | 5ml:1g | Category B (乙) | XN07XXB093B002020103973 | NHSA |
| 山东方明药业集团股份有限公司 | 国药准字H20237125 | 5ml:1g | Category B (乙) | XN07XXB093B002020104083 | NHSA |
| 山东玉满坤生物科技有限公司 | 国药准字H20223200 | 15ml:3g | Category B (乙) | XN07XXB093B002020104145 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20234201 | 15ml:3g | Category B (乙) | XN07XXB093B002020104177 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H37023217 | 5ml:1g | Category B (乙) | XN07XXB093B002020104187 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H33022593 | 5ml:1g | Category B (乙) | XN07XXB093B002020104494 | NHSA |
| 浙江瑞新药业股份有限公司 | 国药准字H33022537 | 5ml:1g | Category B (乙) | XN07XXB093B002020104691 | NHSA |
| 福建省闽东力捷迅药业股份有限公司 | 国药准字H20249777 | 15ml:3g | Category B (乙) | XN07XXB093B002020104799 | NHSA |
| 海南全星制药有限公司 | 国药准字H20234054 | 15ml:3g | Category B (乙) | XN07XXB093B002020105765 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20243199 | 15ml∶3g | Category B (乙) | XN07XXB093B002020109910 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20264088 | 10ml:2g | Category B (乙) | XN07XXB093B002020183093 | NHSA |
| 西安达莫制药有限公司 | 国药准字H20255095 | 15ml:3g | Category B (乙) | XN07XXB093B002020183239 | NHSA |
| 合肥国药诺和药业有限公司 | 国药准字H20253600 | 5ml:1g | Category B (乙) | XN07XXB093B002020183719 | NHSA |
| 湖南赛隆药业(长沙)有限公司 | 国药准字H20254789 | 5ml:1g | Category B (乙) | XN07XXB093B002020183840 | NHSA |
| 嘉亨(珠海横琴)医药科技有限公司 | 国药准字H20264679 | 5ml:1g | Category B (乙) | XN07XXB093B002020184183 | NHSA |
| 黑龙江福和制药集团股份有限公司 | 国药准字H11021885 | 20ml:4g | Category B (乙) | XN07XXB093B002020200075 | NHSA |
| 天津红日药业股份有限公司 | 国药准字H12021150 | 20ml:8g | Category B (乙) | XN07XXB093B002020200864 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32025602 | 5ml:1g | Category B (乙) | XN07XXB093B002020201723 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20093518 | 20ml:4g | Category B (乙) | XN07XXB093B002020201866 | NHSA |
| 石家庄凯达生物工程有限公司 | 国药准字H20253689 | 15ml:3g | Category B (乙) | XN07XXB093B002020202679 | NHSA |
| 上海锦帝九州药业(安阳)有限公司 | 国药准字H41024686 | 20ml:4g | Category B (乙) | XN07XXB093B002020202994 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20067957 | 5ml:1g | Category B (乙) | XN07XXB093B002020203202 | NHSA |
| 广东鼎信医药科技有限公司 | 国药准字H22024146 | 20ml:4g | Category B (乙) | XN07XXB093B002020203331 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H23022874 | 20ml:4g | Category B (乙) | XN07XXB093B002020203820 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20046577 | 5ml:1g | Category B (乙) | XN07XXB093B002020203973 | NHSA |
| 山东方明药业集团股份有限公司 | 国药准字H20237125 | 5ml:1g | Category B (乙) | XN07XXB093B002020204083 | NHSA |
| 山东玉满坤生物科技有限公司 | 国药准字H20223200 | 15ml:3g | Category B (乙) | XN07XXB093B002020204145 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20234201 | 15ml:3g | Category B (乙) | XN07XXB093B002020204177 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H37023217 | 5ml:1g | Category B (乙) | XN07XXB093B002020204187 | NHSA |
| 浙江瑞新药业股份有限公司 | 国药准字H33022537 | 5ml:1g | Category B (乙) | XN07XXB093B002020204691 | NHSA |
| 福建省闽东力捷迅药业股份有限公司 | 国药准字H20249777 | 15ml:3g | Category B (乙) | XN07XXB093B002020204799 | NHSA |
| 海南全星制药有限公司 | 国药准字H20234054 | 15ml:3g | Category B (乙) | XN07XXB093B002020205765 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20243199 | 15ml∶3g | Category B (乙) | XN07XXB093B002020209910 | NHSA |
| 西安达莫制药有限公司 | 国药准字H20255095 | 15ml:3g | Category B (乙) | XN07XXB093B002020283239 | NHSA |
| 合肥国药诺和药业有限公司 | 国药准字H20253600 | 5ml:1g | Category B (乙) | XN07XXB093B002020283719 | NHSA |
| 湖南赛隆药业(长沙)有限公司 | 国药准字H20254789 | 5ml:1g | Category B (乙) | XN07XXB093B002020283840 | NHSA |
| 山东方明药业集团股份有限公司 | 国药准字H20237125 | 5ml:1g | Category B (乙) | XN07XXB093B002020304083 | NHSA |
| 海南全星制药有限公司 | 国药准字H20234054 | 15ml:3g | Category B (乙) | XN07XXB093B002020305765 | NHSA |
| 山东方明药业集团股份有限公司 | 国药准字H20237125 | 5ml:1g | Category B (乙) | XN07XXB093B002020404083 | NHSA |
| 山东方明药业集团股份有限公司 | 国药准字H20237125 | 5ml:1g | Category B (乙) | XN07XXB093B002020504083 | NHSA |
| 江苏苏中药业集团生物制药有限公司 | 国药准字H20055345 | 20ml:4g | Category B (乙) | XN07XXB093B002030101493 | NHSA |
| 石家庄凯达生物工程有限公司 | 国药准字H20253690 | 20ml:4g | Category B (乙) | XN07XXB093B002030102679 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20237071 | 15ml:3g | Category B (乙) | XN07XXB093B002030103202 | NHSA |
| 广东鼎信医药科技有限公司 | 国药准字H22024151 | 5ml:1g | Category B (乙) | XN07XXB093B002030103331 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H37023216 | 10ml:2g | Category B (乙) | XN07XXB093B002030104187 | NHSA |
| 石家庄凯达生物工程有限公司 | 国药准字H20253690 | 20ml:4g | Category B (乙) | XN07XXB093B002030202679 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20237071 | 15ml:3g | Category B (乙) | XN07XXB093B002030203202 | NHSA |
| 江苏苏中药业集团生物制药有限公司 | 国药准字H20055344 | 5ml:1g | Category B (乙) | XN07XXB093B002040101493 | NHSA |
| 江苏苏中药业集团生物制药有限公司 | 国药准字H20055345 | 20ml:4g | Category B (乙) | XN07XXB093B002050101493 | NHSA |
| 江苏苏中药业集团生物制药有限公司 | 国药准字H20055343 | 20ml:8g | Category B (乙) | XN07XXB093B002050201493 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 9 filings and 6 distinct first applicants.
Generic 7 · Supplement 2
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 江苏福邦药业有限公司 | CYHS2601035 | Generic | 2026/05/08 | Not stated by source | CDE |
| 江苏福邦药业有限公司 | CYHS2601034 | Generic | 2026/05/08 | Not stated by source | CDE |
| 成都华宇制药有限公司 | CYHS2601521 | Generic | 2026/06/29 | Not stated by source | CDE |
| 许昌未来制药有限责任公司;许昌未来制药有限公司责任公司 | CYHS2601278 | Generic | 2026/06/04 | Not stated by source | CDE |
| 以岭万洲国际制药有限公司 | CYHS2600266 | Generic | 2026/01/23 | Not stated by source | CDE |
| 丹东医创药业有限责任公司 | CYHB2550412 | Supplement | 2025/12/27 | Not stated by source | CDE |
| 丹东医创药业有限责任公司 | CYHB2550411 | Supplement | 2025/12/27 | Not stated by source | CDE |
| 华中药业股份有限公司 | CYHS2502825 | Generic | 2025/08/06 | Not stated by source | CDE |
| 华中药业股份有限公司 | CYHS2502824 | Generic | 2025/08/06 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 5 filings and 4 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 江苏福邦药业有限公司 | CYHS2601035 | Generic | 2026/05/08 | Not stated by source | CDE |
| 江苏福邦药业有限公司 | CYHS2601034 | Generic | 2026/05/08 | Not stated by source | CDE |
| 成都华宇制药有限公司 | CYHS2601521 | Generic | 2026/06/29 | Not stated by source | CDE |
| 许昌未来制药有限责任公司;许昌未来制药有限公司责任公司 | CYHS2601278 | Generic | 2026/06/04 | Not stated by source | CDE |
| 以岭万洲国际制药有限公司 | CYHS2600266 | Generic | 2026/01/23 | Not stated by source | CDE |
API registrations
Non-component matches: 16 companies with A status and 4 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 吡拉西坦 | 上海锦帝九州药业（安阳）有限公司 | Y20260000835 | I | Exact ingredient | 2026/10/13 | CDE |
| 吡拉西坦 | 石药集团欧意药业有限公司 | Y20260000791 | I | Exact ingredient | 2026/09/14 | CDE |
| 吡拉西坦 | 山东海佑福瑞达制药有限公司 | Y20250001483 | I | Exact ingredient | 2026/01/09 | CDE |
| 吡拉西坦 | 石家庄市普力制药有限公司 | Y20240000626 | A | Exact ingredient | 2025/12/05 | CDE |
| 吡拉西坦 | 湖南赛隆药业有限公司 | Y20230000964 | A | Exact ingredient | 2025/01/21 | CDE |
| 吡拉西坦 | 江西亿友药业有限公司 | Y20230000088 | A | Exact ingredient | 2024/09/14 | CDE |
| 吡拉西坦 | 广安凯特制药有限公司 | Y20220000267 | A | Exact ingredient | 2024/01/03 | CDE |
| 吡拉西坦 | 江西跃华药业有限公司 | Y20190008801 | A | Exact ingredient | 2025/09/17 | CDE |
| 吡拉西坦 | 福建省福抗药业股份有限公司 | Y20190008745 | A | Exact ingredient | 2024/08/01 | CDE |
| 吡拉西坦 | 重庆青阳药业有限公司 | Y20190005388 | A | Exact ingredient | 2026/02/26 | CDE |
| 吡拉西坦 | 江苏吴中医药集团有限公司苏州制药厂 | Y20190004967 | A | Exact ingredient | 2025/08/05 | CDE |
| 吡拉西坦 | 常州亚邦制药有限公司 | Y20190004950 | A | Exact ingredient | 2025/08/16 | CDE |
| 吡拉西坦 | 南京鲸轮制药有限公司 | Y20190004515 | A | Exact ingredient | 2025/06/05 | CDE |
| 吡拉西坦 | 江苏联环药业股份有限公司 | Y20190004428 | A | Exact ingredient | 2025/07/29 | CDE |
| 吡拉西坦 | 东北制药集团股份有限公司 | Y20190003834 | A | Exact ingredient | 2024/12/27 | CDE |
| 吡拉西坦 | 华中药业股份有限公司 | Y20190003125 | A | Exact ingredient | 2025/06/11 | CDE |
| 吡拉西坦 | 天津中津药业股份有限公司 | Y20190002544 | A | Exact ingredient | — | CDE |
| 吡拉西坦 | 亚宝药业集团股份有限公司 | Y20190002314 | A | Exact ingredient | 2026/09/05 | CDE |
| 吡拉西坦 | 上海现代哈森（商丘）药业有限公司 | Y20190001696 | A | Exact ingredient | 2025/03/12 | CDE |
| 吡拉西坦 | 山东威高药业有限公司 | Y20170000198 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Piracetam Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy